Pulmonary Disease, Chronic Obstructive
938
21
30
755
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
315 trials with published results (34%)
Research Maturity
755 completed trials (80% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
5.2%
49 terminated out of 938 trials
93.9%
+7.4% vs benchmark
29%
271 trials in Phase 3/4
42%
315 of 755 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 755 completed trials
Clinical Trials (938)
Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GSK3862995B Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and European Ancestry
Detecting Systemic Carbon Dioxide Levels With a Novel Biosensor
Innate Immunity in Ozone-induced Airway Inflammation in COPD
Involvement of Skeletal Muscle Fibrocytes in sarcOpenia in Patients With Chronic ObstRuctive Pulmonary Disease
A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity
Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave
Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD
Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting
Benefits of Epithelial Repair in COPD by Induced Pluripotent Stem Cells (iPS)
Internet-based Rehabilitation Aftercare Focusing on Physical Activity Promotion in Persons With COPD
Development and Validation of the GLORI-COPD Score
Monitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD Exacerbations
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD
Circulating Tumor Cells in Lung Cancer Screening
A Study of the Effect of a Nurse Navigator Program on High Risk Patients
Changes in Dyspnea, Activity and Sleep in COPD by Video-Based Breathing Exercises
Trial to Determine Effective Aspirin Dose in COPD